BNP Paribas Financial Markets’s Vigil Neuroscience VIGL Stock Holding History

BNP Paribas Financial Markets’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-150	Closed	-$1.19K	–	5789
2025 Q2	$1.19K	Hold	150	–	–	﹤0.01%	5125
2025 Q1	$267	Sell	150 -78	-34%	-$175	﹤0.01%	5192
2024 Q4	$388	Buy	+228	New	+$673	﹤0.01%	5194

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BNP Paribas Financial Markets's VIGL Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 150 shares — an estimated $1.19K sold.

BNP Paribas Financial Markets first reported a position in VIGL in Q4 2024 and held it in 3 quarters. The position peaked at $1.19K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

BNP Paribas Financial Markets reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 150 Vigil Neuroscience shares in Q3 2025, an estimated $1.19K.
BNP Paribas Financial Markets first reported a position in Vigil Neuroscience in Q4 2024 and held it in 3 quarters.
BNP Paribas Financial Markets's Vigil Neuroscience position peaked at $1.19K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.